18:32 IST
BSE
Annual Report
Aurobindo Pharma Annual Report
Aurobindo Pharma Limited has submitted its Integrated Annual Report for FY 2025-26, alongside the notice for its 39th Annual General Meeting.
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,680.80
- Market cap
- ₹97,621 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.8×Sector 47.4×
- Promoter holding
- 51.88%+0.06% QoQ
- FII holding
- 16.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 17Regulatory Approval 9Business Update 8Management Change 4Earnings Call 4Other Announcement 3Financial Results 3Board Meeting Outcome 2Board Meeting Date 2Annual General Meeting 2Results Update 1Production Started 1Product Launch 1Legal & Regulatory 1Debt & Borrowing 1Capacity Expansion 1Annual Report 1Adverse Business Impact 1Acquisition 1
Time
1 announcement with these filters